Abstract
Waldenström macroglobulinemia (WMG) is a lymphoproliferative disorder characterized by good initial responses to standard therapeutics, but only a minority of patients achieve complete remissions, and most inevitably relapse, indicating a need for novel agents. B-cell receptor signaling has been linked to clonal evolution in WMG, and Spleen tyrosine kinase (Syk) is overexpressed in primary cells, suggesting that it could be a novel and rational target. We studied the impact of the Syk inhibitor fostamatinib on BCWM.1 and MWCL-1 WMG-derived cell lines both in vitro and in vivo, as well as on primary patient cells. In WMG-derived cell lines, fostamatinib induced a time- and dose-dependent reduction in viability, associated with activation of apoptosis. At the molecular level, fostamatinib reduced activation of Syk and Bruton's tyrosine kinase, and also downstream signaling through MAPK kinase (MEK), p44/42 MAPK, and protein kinase B/Akt. As a single agent, fostamatinib induced tumor growth delay in an in vivo model of WMG, and reduced viability of primary WMG cells, along with inhibition of p44/42 MAPK signaling. Finally, fostamatinib in combination with other agents, including dexamethasone, bortezomib, and rituximab, showed enh...Continue Reading
References
Feb 9, 1996·Science·D J RawlingsJ P Kinet
May 1, 1996·Immunity·H ParkO N Witte
May 16, 1998·The Journal of Biological Chemistry·M DeckertY C Liu
Aug 10, 2000·The Journal of Biological Chemistry·J ZhangR P Siraganian
Jan 3, 2001·Blood·B CiricL R Pease
Dec 18, 2001·The EMBO Journal·N RaoH Band
Mar 14, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine I ChenUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jun 5, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Steven P TreonAshraf Badros
Sep 1, 2007·Experimental Hematology·Daniel Ditzel SantosSteven P Treon
Sep 1, 2007·Blood·Xavier LeleuIrene M Ghobrial
Mar 13, 2008·Blood·Xavier LeleuIrene M Ghobrial
Dec 8, 2009·Blood·Jonathan W FriedbergMargaret A Shipp
Dec 8, 2009·Blood·Aldo M RoccaroIrene M Ghobrial
Feb 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Irene M GhobrialThomas E Witzig
Aug 13, 2010·Mayo Clinic Proceedings·Stephen M AnsellMorie A Gertz
Dec 30, 2010·The Journal of Biological Chemistry·Chad C BjorklundRobert Z Orlowski
Jan 18, 2011·Hematology·Thomas E Witzig, Mamta Gupta
Mar 19, 2011·Blood·Lucy S HodgeStephen M Ansell
Mar 29, 2011·Expert Opinion on Investigational Drugs·Dimitar G Efremov, Luca Laurenti
Apr 22, 2011·American Journal of Hematology·Efstathios KastritisMeletios A Dimopoulos
Apr 28, 2011·American Journal of Hematology·Morie A Gertz
Aug 17, 2011·Blood·Richard J JonesRobert Z Orlowski
Aug 31, 2012·The New England Journal of Medicine·Steven P TreonZachary R Hunter
Sep 5, 2012·Leukemia·N GachardJ Feuillard
Nov 21, 2012·American Journal of Hematology·Sigurdur Y KristinssonMagnus Björkholm
Nov 30, 2012·British Journal of Clinical Pharmacology·Muhammad BaluomDavid T W Lau
Jan 5, 2013·Blood·Irene M GhobrialJeffrey Matous
Jan 17, 2013·Blood·Lian XuSteven P Treon
Jan 29, 2013·Blood·Marzia VarettoniMario Cazzola
Mar 1, 2013·Leukemia·C JiménezR García-Sanz
Mar 26, 2013·Current Opinion in Pharmacology·David L Simmons
Jul 10, 2013·Blood·Guang YangSteven P Treon
Jul 26, 2013·Nature Reviews. Immunology·Robert C Rickert
Oct 12, 2013·British Journal of Haematology·Amin Aalipour, Ranjana H Advani
Dec 25, 2013·Blood·Zachary R HunterSteven P Treon
Jan 11, 2014·Expert Review of Hematology·Ilyas SahinIrene M Ghobrial
Jun 11, 2014·Leukemia·Y CaoS P Treon
Citations
Feb 13, 2016·Leukemia·K V ArgyropoulosM L Palomba
Apr 5, 2016·Oncogene·E MandatoF Piazza
Nov 9, 2016·Best Practice & Research. Clinical Haematology·Aneel PaulusAsher Chanan-Khan
Nov 9, 2016·Best Practice & Research. Clinical Haematology·Sikander AilawadhiAsher Chanan-Khan
Jun 3, 2020·Cancers·Dimitar G EfremovLuca Laurenti
Jul 8, 2020·Expert Review of Anticancer Therapy·Maria GavriatopoulouMeletios Athanasios Dimopoulos
Mar 29, 2018·Biomedicines·Paula GrondonaAnja Schmitt
Feb 2, 2020·Blood Cancer Journal·Manit MunshiGuang Yang
Sep 22, 2020·Expert Opinion on Emerging Drugs·Fotiou DespinaKastritis Efstathios
Feb 17, 2017·Cancer Research·Ye CuiSouheil El-Chemaly
Mar 25, 2017·Molecular Cancer Therapeutics·Stuart W EmberErnst Schönbrunn
Jun 18, 2021·Expert Opinion on Drug Safety·Magdalini MigkouMeletios Athanasios Dimopoulos
Jul 27, 2021·Frontiers in Genetics·Guofeng ZhouXiao Li
Aug 8, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Essam EzzeldinRashad Alsalahi